ocv-501
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2011 (NCT01440920)
Timeline
Indications
Studied for
Mechanism of action
- Wilms tumor proteinImmunity, active
immunity, active - wt1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ocv-501
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01961882 | Phase 2 | Oct 1, 2013 | Otsuka |
| NCT01475370 | Phase 1 | Nov 1, 2011 | Otsuka |
| NCT01440920 | Phase 1 | Sep 1, 2011 | Otsuka |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 3 | 3 | 2 | 2011 |
1 organizations
Page 1 / 1